Post-translational Modification Control of HBV Biological Processes
Hepatitis B virus infection remains a global healthy issue that needs to be urgently solved. Novel strategies for anti-viral therapy are based on exploring the effective diagnostic markers and therapeutic targets of diseases caused by hepatitis B virus (HBV) infection. It is well-established that no...
Main Author: | Fan Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-11-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fmicb.2018.02661/full |
Similar Items
-
Evaluation of the HBV liver reservoir with fine needle aspirates
by: Barbara Testoni, et al.
Published: (2023-10-01) -
Dynamics of HBV cccDNA expression and transcription in different cell growth phase
by: Chong Chin-Liew, et al.
Published: (2011-12-01) -
ZNF148 inhibits HBV replication by downregulating RXRα transcription
by: Xinyan Yao, et al.
Published: (2024-01-01) -
Current Status and Challenges in Anti-Hepatitis B Virus Agents Based on Inactivation/Inhibition or Elimination of Hepatitis B Virus Covalently Closed Circular DNA
by: An-Qi Zhuang, et al.
Published: (2023-11-01) -
JMJD2D stabilises and cooperates with HBx protein to promote HBV transcription and replication
by: Xu Kong, et al.
Published: (2023-10-01)